Business
Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced updated full year guidance for fiscal year 2025 (year ended January 3, 2026) and its initial full year guidance for fiscal year 2026 (year ending January 2, 2027). Updated Full Year 2025 Guidance (year ending January 3, 2026): For the full fiscal year 2025, we expect to
About this update from Aveanna Healthcare Holdings Inc.
[{"type":"image","alt":"Aveanna Healthcare Holdings, Inc","displaySize":"","headline":null,"caption":"Aveanna Healthcare Holdings, Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/33912684a687558cfff7d22c7b0ea842"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/V2w4__cWUsNbnIrky0m0UQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/33912684a687558cfff7d22c7b0ea842","width":300,"height":157}},"lazy":false},{"type":"text","content":"ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced updated full year guidance for fiscal year 2025 (year ended January 3, 2026) and its initial full year guidance for fiscal year 2026 (year ending January 2, 2027).","length":392,"tagName":"p"},{"type":"text","content":"Updated Full Year 2025 Guidance (year ending January 3, 2026):","length":62,"tagName":"p"},{"type":"text","content":"For the full fiscal year 2025, we expect to report:","length":51,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of approximately $2.425 billion to $2.445 billion, updated from greater than $2.375 billion.","length":100,"tagName":"p"}]},{"val":[{"type":"text","content":"Net income of approximately $181 million to $220 million.","length":57,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA of approximately $318 million to $322 million, updated from greater than $300 million.","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"Normalized Adjusted EBITDA of approximately $298 million to $302 million.","length":73,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":332,"olType":false},{"type":"text","content":"Initial Full Year 2026 Guidance (year ending January 2, 2027):","length":62,"tagName":"p"},{"type":"text","content":"The following is our guidance reflecting our current expectations for revenue and adjusted EBITDA for the full fiscal year 2026:","length":128,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of between $2.54 and $2.56 billion.","length":43,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":43,"olTy...